Abiraterone Acetate for Nonmetastatic Castration-Resistant Prostate Cancer-The Forgotten Dance Partner?

JAMA Oncol. 2019 Feb 1;5(2):144-145. doi: 10.1001/jamaoncol.2018.5191.

Authors

Zachary Klaassen^{1

2}, Christopher J D Wallis², Neil E Fleshner²

Affiliations

¹ Division of Urology, Medical College of Georgia, Augusta University, Augusta.
² Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

PMID: 30489621
DOI: 10.1001/jamaoncol.2018.5191

No abstract available

MeSH terms

Abiraterone Acetate / administration & dosage*
Abiraterone Acetate / adverse effects
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Disease Progression
Humans
Male
Progression-Free Survival
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Prostatic Neoplasms, Castration-Resistant / mortality
Prostatic Neoplasms, Castration-Resistant / pathology
Randomized Controlled Trials as Topic

Substances

Abiraterone Acetate